The DOI matches its Crossref record.
Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States
Open accessAbstract
Pertussis has shown a striking resurgence in the United States, with a return to record numbers of reported cases as last observed in the 1950s.Bordetella pertussis isolates lacking pertactin, a key antigen component of the acellular pertussis vaccine, have been observed, suggesting that B. pertussis is losing pertactin in response to vaccine immunity. Screening of 1,300 isolates from outbreak and surveillance studies (historical isolates collected from 1935 up to 2009, isolates from the 2010 California pertussis outbreak, U.S. isolates from routine surveillance between 2010-2012, and isolates from the 2012 Washington pertussis outbreak) by conventional PCR and later by Western blotting and prn sequencing analyses ultimately identified 306 pertactin-deficient isolates. Of these pertactin-deficient strains, 276 were identified as having an IS 481 in the prn gene (prn IS 481 positive). The first prn IS 481-positive isolate was found in 1994, and the next prn IS 481-positive isolates were not detected until 2010. The prevalence of pertactin-deficient isolates increased substantially to more than 50% of collected isolates in 2012. Sequence analysis of pertactin-deficient isolates revealed various types of mutations in the prn gene, including two deletions, single nucleotide substitutions resulting in a stop codon, an inversion in the promoter, and a single nucleotide insertion resulting in a frameshift mutation. All but one mutation type were found in prn 2 alleles. CDC 013 was a predominant pulsed-field gel electrophoresis (PFGE) profile in the pertactin-positive isolates (203/994) but was found in only 5% (16/306) of the pertactin-deficient isolates. Interestingly, PFGE profiles CDC 002 and CDC 237 represented 55% (167/306) of the identified pertactin-deficient isolates. These results indicate that there has been a recent dramatic increase in pertactin-deficient B. pertussis isolates throughout the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bordetella pertussis pathogenesis: current and future challenges
Melvin, J. A., Scheller, E. V., Miller, J. F., & Cotter, P. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3235 · Cited by 363
Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States
Aloe, C., Kulldorff, M., & Bloom, B. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700240114 · Cited by 51
Metadata
- Authors
- Pawloski, L. C., Queenan, A. M., Cassiday, P. K., Lynch, A. S., Harrison, M. J., Shang, W., Williams, M. M., Bowden, K. E., Burgos-Rivera, B., Qin, X., Messonnier, N., & Tondella, M. L.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2013-11-20
- Volume
- 21
- Issue
- 2
- Pages
- 119-125
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2111082083
- Cited by
- 221
- References
- 0
- FWCI
- 27.46
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States. https://app.cochat.ai/papers/10.1128/cvi.00717-13
- The paper
- Pawloski, L. C., Queenan, A. M., Cassiday, P. K., Lynch, A. S., Harrison, M. J., Shang, W., Williams, M. M., Bowden, K. E., Burgos-Rivera, B., Qin, X., Messonnier, N., & Tondella, M. L. (2014). Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States. Clinical and Vaccine Immunology. https://doi.org/10.1128/cvi.00717-13
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.